GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
4B3V | P08563 | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate | |
4B3V | 4B3V | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate | |
6WAQ | 6WAQ | Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72 | |
6WAQ | P59594 | Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72 | |
8QH1 | A0A8A5XRG7 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
8QH1 | 8QH1 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
8QH1 | Q6PJF2 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
7CHB | 7CHB | Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab | |
7CHB | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab | |
7B3O | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab | |
7B3O | 7B3O | Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab | |
7VNB | 7VNB | Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 | |
7VNB | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 | |
7QF0 | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325 | |
7QF0 | 7QF0 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325 | |
7QF1 | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 | |
7QF1 | 7QF1 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 | |
7QEZ | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022 | |
7QEZ | 7QEZ | Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022 | |
8QH0 | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 | |
8QH0 | 8QH0 | Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 | |
8QH0 | Q6PJF2 | Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 | |
8BEC | 8BEC | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1375 scFV | |
8BEC | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1375 scFV | |
8BG1 | 8BG1 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1511 scFV | |
8BG1 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1511 scFV | |
8BG2 | 8BG2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1580 scFV | |
8BG2 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1580 scFV | |
8BG3 | 8BG3 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1610 scFV | |
8BG3 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1610 scFV | |
8BG4 | 8BG4 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1611 scFV | |
8BG4 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1611 scFV | |
8BG5 | 8BG5 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1631 scFV | |
8BG5 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1631 scFV | |
8SK5 | P0DTC2 | Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain | |
8SK5 | 8SK5 | Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain | |
8SGU | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain | |
6YLA | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab | |
6YLA | 6YLA | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab | |
7SPP | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02 | |
7SPP | 7SPP | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02 | |
7SPO | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4 | |
7SPO | 7SPO | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4 | |
8FHY | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5021 | |
8FHY | 8FHY | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5021 | |
7N3I | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
7N3I | 7N3I | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
7WBZ | P0DTC2 | Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303 | |
7WBZ | 7WBZ | Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303 | |
7C00 | Q6ZMJ2 | Crystal structure of the SRCR domain of human SCARA5. |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024